Inaktiver Wert

Advanced Cell Technology, Inc. Aktie OTC Bulletin Board

Aktien

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	10.02.16
Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	22.01.16
Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	28.12.15
Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	03.12.15
OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	11.11.15

Manager	Titel	Alter	Seit
Yoshitsuga Shitaka PSD	President	-	-
John Heffernan PRN	Corporate Officer/Principal	-	03.02.15

Aufsichtsräte	Titel	Alter	Seit
Percival Barretto-Ko BRD	Director/Board Member	51	-
Masaaki Hirano BRD	Director/Board Member	57	-
Toru Yoshimitsu BRD	Director/Board Member	61	-

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+18,72 %	123 Mrd.
REGENERON PHARMACEUTICALS, INC.	+14,53 %	107 Mrd.
BIONTECH SE	-2,88 %	24,01 Mrd.
ARGENX SE	+2,18 %	22,59 Mrd.
GENMAB A/S	-10,09 %	18,16 Mrd.
WUXI APPTEC CO., LTD.	-41,04 %	16,84 Mrd.
BEIGENE, LTD.	-11,83 %	16,23 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+1,46 %	13,43 Mrd.
SAREPTA THERAPEUTICS, INC.	+24,22 %	11,32 Mrd.